William C Dooley

Title: The Innovations of William C. Dooley

Introduction

William C. Dooley is an accomplished inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of breast malignancy. With a total of 3 patents to his name, Dooley's work has the potential to impact the lives of many patients.

Latest Patents

One of Dooley's notable inventions is focused on aberrantly methylated genes as markers of breast malignancy. This invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes, including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARβ), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, HIN-1, RASSF1A, and combinations of such genes, serve as markers of breast malignancy. This innovative approach offers a promising avenue for early detection and diagnosis.

Career Highlights

William C. Dooley is affiliated with Johns Hopkins University, where he continues to advance his research and innovations. His work is characterized by a commitment to improving diagnostic methods and patient outcomes in oncology.

Collaborations

Dooley has collaborated with esteemed colleagues, including Saraswati Vaidyanathan Sukumar and Ella Evron. These partnerships enhance the depth and breadth of his research efforts.

Conclusion

William C. Dooley's contributions to the field of medical diagnostics, particularly in breast malignancy, highlight his innovative spirit and dedication to improving healthcare. His patents represent significant advancements that could lead to better diagnostic tools for patients.